Crossmark

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

Crossref DOI link: https://doi.org/10.1007/s11095-022-03302-1

Published Online: 2022-06-01

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mahapatra, Manoj K.

Karuppasamy, Muthukumar

Sahoo, Biswa M.
License Information

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-06-01
More Information

Article History

Received: 21 March 2022

Accepted: 23 May 2022

First Online: 1 June 2022

Conflicts of Interest

: The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Document is current

Any future updates will be listed below